Please login to the form below

Not currently logged in
Email:
Password:

Dr Keith Bragman joins Alacrita

He becomes a partner at the firm’s London office

Alacrita Dr Keith BragmanLife sciences consultancy Alacrita has appointed Dr Keith Bragman as a partner in its London office.

Dr Bragman brings a wealth of industry experience to the firm, having served on the Science and Technology Select Committee at the House of Commons, worked with the Bill and Melinda Gates Foundation and at the UK government's department for international development.

He has held a number of senior leadership positions at pharmaceutical companies, including serving as head of global development and research for UCB's Japanese business, vice president and senior partner for biotechnology at Quintiles, and European head of clinical oncology at Bristol-Myers Squibb.

Managing partner Anthony Walker said: “We are delighted to welcome Keith to our product development practice as we build a best-in-class consulting practice to help companies develop better therapeutics.

“Keith is an experienced executive with deep and broad knowledge of the drug development process and a sound understanding of the challenges faced by senior management.

“He joins a high calibre team of seasoned consultants and underlines our commitment to providing exceptionally high quality advice to the industry.”

30th June 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

White Paper for download - Explaining the price of your product
In this white paper, he breaks down the pricing options available to you, shares stories from his extensive experiences, and talks you through how to better define your pricing, step-by-step....
OPEN Health expands offering with the launch of a new Learning & Development specialist team
Enhanced expertise to deliver impactful internal training programmes for healthcare clients...
Figure 1 Clarivate
The changing nature of approvals – what does the future hold?
The 2019 CMR International Pharmaceutical R&D Factbook...

Infographics